Biogen pays $125M for mid-stage, experimental multiple sclerosis drug

If approved, the drug would be Biogen's seventh for MS.

Source: bizjournals.com Health Care:Pharmaceuticals headlines - July 13, 2021 Category: Pharmaceuticals Authors: Rowan Walrath Source Type: news